Inflammation-specific peptides and the uses thereof

Details Inflammation-specific peptides and the uses thereof Inflammation-specific peptides and the uses thereof

2006-12-26

2006-12-26

Mertz, Prema (Department: 1646)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007210

Reexamination Certificate

active

07153662

ABSTRACT:
The invention relates to novel peptides and partial peptide sequences for the diagnosis and therapy of inflammations and sepsis, which are formed in the case of inflammations and/or infections of primates and humans, and their use or the use of antibodies formed against these peptides in diagnosis and therapy.

REFERENCES:
patent: 5639617 (1997-06-01), Bohuon
patent: 5660994 (1997-08-01), Bruder-Heid et al.
patent: 198 47 690 (2000-04-01), None
patent: 0 656 121 (1998-03-01), None
patent: WO 98/11217 (1998-03-01), None
patent: WO009811217 (1998-03-01), None
patent: WO 99/47669 (1999-09-01), None
patent: WO 00/22439 (2000-04-01), None
Liddell, E. and Weeks, I. Antibody Technology Bios Scientific Pub Ltd, Chapter 5, p. 65-83, 1995.
Aird, “The Hematologic System as a Marker of Organ Dysfunction in Sepsis,”Mayo Clin, Proc., 78:869-881, 2003.
Carrigan et al., “Toward Resolving the Challenges of Sepsis Diagnosis,”Clin. Chem., 50(8):1301-1314, 2004.
Hotchkiss and Karl, “The Pathophysiology and Treatment of Sepsis,”N. Engl. J. Med., 348(2):138-150, 2003.
Marshall et al., “Measures, Markers, and Mediators: Toward a Staging System for Clinical Sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, Oct. 25-26, 2000,”Crit. Care Med., 31(5):1560-1567, 2003 (Abstract only).
Oberholzer et al., “Sepsis Syndromes: Understanding the Role of Innate and Acquired Immunity,”Shock, 16(2):83-96, 2001 (Abstract only).
Assicot, et al., “High Serum Procalcitonin Concentrations in Patients with Sepsis and Infection,”Lancet, 341(8844):515-518, 1993.
Beishuizen et al., “Endogenous Mediators in Sepsis and Septic Shock,”Advances Clin. Chem., 33:55-131, 1999.
Calandra et al., “Protection from Septic Shock by Neutralization of Macrophage Migration Inhibitory Factor,”Nature Medicine, 6(2):164-170, 2000.
Gabay and Kushner, “Acute-Phase Proteins and Other Systemic Responses to Inflammation,”New Engl. J. Med., 340(6):448-454, 1999.
Garber, “Protein C May Be Sepsis Solution,”Nature Biotechnology, 18:917-918, 2000.
Ghillani et al., “Monoclonal Antipeptide Antibodies as Tools to Dissect Closely Related Gene Products,”J. Immunol., 141(9):3156-3163, 1988.
Ghillani et al., “Identification and Measurement of Calcitonin Precursors in Serum of Patients with Malignant Diseases,”Cancer Research, 49(23):6845-6851, 1989.
Heukeshoven and Dernick, “Improved Silver Staining Procedure for Fast Staining in PhastSystem Development Unit. I. Staining of Sodium Dodecyl Sulfate Gels,”Electrophoresis, 9(1):28-32, 1988.
Karzai, et al., “Procalcitonin—A New Indicator of the Systemic Response to Severe Infections,”Infection, 25:3-8, 1997.
Klose, “Fractionated Extraction of Total Tissue Proteins from Mouse and Human for 2-D Electrophoresis,”In: Methods in Molecular Biology, vol. 112, 2-D Proteame Analysis Protocols, Humana Press Inc., N.J., pp. 67-85.
Klose and Kobalz, “Two-Dimensional Electrophoresis of Proteins: An Updated Protocol and Implications for a Functional Analysis of the Genome,”Electrophoresis, 16:1034-1059, 1995.
Lamerdin et al., EMBL Database Accession No. 075272.
Lingner et al., “Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase,”Science, 276:561-567, 1997.
Mann and Pandey, “Use of Mass Spectrometry-Derived Data to Annotate Nucleotide and Protein Sequence Databases,”TRENDS Biochem. Sci., 26(1):54-61, 2001.
Neubauer et al., Mass Spectrometry and EST-Database Searching Allows Characterization of the Multi-Protein Spliceosome Complex,Nature Genetics, 20:46-50, 1998.
Oczenski et al., “Procalcitonin: A New Parameter for the Diagnosis of Bacterial Infection in the Peri-Operative Period,”Eur. J. Anaesthesiol., 15:202-209, 1998.
Otto et al., “Identification of Human Myocardial Proteins Separated by Two-Dimensional Electrophoresis Using an Effective Sample Preparation for Mass Spectrometry,”Electrophoresis, 17:1643-1650, 1996.
Panacek, “Anti-TNF Strategies,”Intensive Care Med., 23:1144-1149, 1997.
Redl et al., “Procalcitonin Release Patterns in a Baboon Model of Trauma and Sepsis: Relationship to Cytokines and Neopterin,”Crit. Care Med., 28(11):3659-3663, 2000.
Redl and Schlag, “Non-Human Primate Models of Sepsis,”Sepsis, 2:243-253, 1998.
Reinhart et al., “Sepsis Und Spetischer Schcok,”Intensivmedizin, 756-760, 2001.
International Search Report for PCT Application Serial No. PCT/EP02/04219, mailed Oct. 11, 2002.

Affiliated with

Also associated with

Rating

Inflammation-specific peptides and the uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inflammation-specific peptides and the uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inflammation-specific peptides and the uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3671906